Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 –– ...

Blood pressure medications are usually taken for life. However, some people can stop taking them by addressing those underlying causes of high blood pressure (hypertension) that can be changed, such ...

MANP was originally discovered by John C. Burnett Jr., MD, Director of the Cardiorenal Research Laboratory at Mayo Clinic. E-Star and Mayo Clinic entered into a worldwide exclusive license agreement ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE ... for the treatment of Resistant Hypertension (BOLD-HTN). MANP was originally discovered by John C. Burnett Jr., MD, Director of the Cardiorenal ...

and ocular hypertension (OHT). The Phase II trials (Osprey and Apteryx) successfully met all primary and secondary endpoints. Qlaris Bio will present a corporate update at the Glaucoma 360 New ...

Globe Life earned 2.5 stars out of 5 for overall performance. Founded in 1951, Globe Life offers a mix of term and permanent life insurance. The company highlights its initial low cost ...